1TO2 | date | |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | 15P, CA, CIT, NA | enzyme |
| ||||||||||||
note | 1TO2 is a representative structure | ||||||||||||||
related structures | by homologous chain: 1CSE, 1TM5 | ||||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Binding, proteolytic, and crystallographic analyses of mutations at the protease--inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex., Radisky ES, Kwan G, Karen Lu CJ, Koshland DE Jr, Biochemistry 2004 Nov 2;43(43):13648-56. PMID:15504027 |
Data retrieval |
View 1TO2 in 3D |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |